


Vol 27, No 9 (2016)
- Year: 2016
- Articles: 20
- URL: https://journals.eco-vector.com/0236-3054/issue/view/5961
Articles
METHOD OF SPONTANEOUS REPORTS AS AN INSTRUMENT CONTROLING WIDELY USED INTERCHANGEABLE DRUGS
Abstract
Method of spontaneous reports was used to identify adverse reactions associated with the replacement of the drugs with the same international nonproprietary name. The analysis of 7224 spontaneous reports in Russian data base for the period from 1 January 2015 to 30 June 2015 was done. Information about adverse reactions that occur when there was the replacement of drugs was detected in 1.9% of cases. The obtained results allowed to detect the following groups of drugs for which it was revealed the largest number of spontaneous reports of adverse reactions associated with the replacement of drugs: anti-epileptic drugs (45.9%), drugs with a narrow therapeutic index (39.2%), biologic drugs (3.7%), pancreatin (4.4%), ipratropium bromide+fenoterol (2.2%), drugs used in pediatrics (34.1%). Data that were obtained via method of spontaneous reports can be used for the primary and repeated evaluation interchangeability of medicinal drugs.
Vrach. 2016;27(9):2-5









CURRENT POSSIBILITIES FOR TREATING ATRIAL FIBRILLATION
Abstract
The paper considers possibilities for enhancing the efficiency of antiarrhythmic drug therapy for atrial fibrillation, as well as the latest advances in its non-drug therapy, particularly catheter ablation in the left atrium and lifestyle modification in patients.
Vrach. 2016;27(9):14-20



THE HEART IN DUST-INDUCED LUNG DISEASES ACCORDING TO ECHOCARDIOGRAPHIC DATA
Abstract
The paper describes the characteristics of the structural and functional status of the heart, the status and performance of its right and left chambers in Stages I and II chronic dust-induced bronchitis, silicosis, and pneumoconiosis caused by welding aerosols. The investigators have revealed the specific features of development of hemodynamic disorders and a change in myocardial contractility in these diseases.
Vrach. 2016;27(9):21-24















ZINC DEFICIENCY AS A RISK FACTOR FOR PREGNANCY COMPLICATIONS
Abstract
Clinical and laboratory studies were conducted in 162 women in the first trimester of pregnancy (at 11-14 weeks of gestation). The high prevalence (71.6%) of zinc deficiency was found among pregnant women. Zinc deficiency increased the risk of pregnancy complications (gestational diabetes, miscarriage, and preterm birth) and somatic diseases (chronic pyelonephritis, hypertensive states).
Vrach. 2016;27(9):46-49



INSULINOMA IS A RARE AND DIFFICULT-TO-DIAGNOSE CAUSE OF HYPOGLYCEMIA
Abstract
The paper discusses the problem of diagnosing an insulin-producing tumor arising from the islets of Langerhans ß cells with manifestations of severe hypoglycemic syndrome. It provides information on the pathogenesis and clinical picture of insulinoma and methods for its diagnosis and treatment. A specific clinical example is given to trace the course of hypoglycemic syndrome in organic hyperinsulinism in a 26-year-old pregnant woman, difficulties in topical diagnosis, and the role of high-tech medical care.
Vrach. 2016;27(9):49-54






THE CARDIOVASCULAR SYSTEM AND NT-proBNP LEVELS IN DIFFUSE TOXIC GOITER
Abstract
The level of NT-terminal precursor of brain natriuretic peptide was ascertained to be related to the gender and age of patients with thyrotoxicosis: there was its positive correlation with the size of some heart cavities and its negative correlation with left ventricular ejection fraction.
Vrach. 2016;27(9):57-59









TECHNOLOGY ASSESSMENT OF CENTRAL PRESSURE AS EFFECTIVE TOOL FOR YOUTH'S PREVENTIVE EXAMINATION
Abstract
The paper presents data of evaluation of the profile of risk factors and central pressure in 80 students in the course of their preventive examination. It turned out higher representation of system and hidden hypertension / prehypertension in students with risk factors and same incidence of false forms of pressure increasing.
Vrach. 2016;27(9):70-72









ANTICOAGULANT THERAPY IN PATIENTS WITH PROSTHETIC HEART VALVES
Abstract
The problem of anticoagulant therapy in patients with prosthetic heart valves (PHV) is due to the type of a prosthesis, on the one hand, and to the differences in a drug response to the indirect anticoagulant warfarin, caused by external, internal, and genetic factors, on the other. So far the problems associated with the quality of controlling the level of hypocoagulation have not been solved; the use of pharmacogenetic tests relevant for warfarin susceptibility has been limited; approaches to enhancing treatment adherence in patients with PHV have not been elaborated.
Vrach. 2016;27(9):78-81





